Windhover
Home
Home		 Register
Register		 Login
Log In		 Schedule
Schedule		 Information
Info		 Attending Companies
Attendees		 Contact
Contact		 Help
Help
April 28-30 2010Paris Marriott Rive Gauche Hotel & Conference CenterParis, France

IN3 events bring together early/mid/late-stage, medical technology innovators with investors, venture capitalists, and business development executives - all in a single forum. Network with the biggest, medical device dealmakers in financing, partnering, and M&A!

IN3 Investor Day - April 28 IN3 Main Event - April 29-30
Investor Day is key for medtech innovators who are interested in what investment leaders in the industry are thinking, doing, and planning. Venture and investment officials will speak about what interests them most in medical device technologies, therapeutic areas, products, and geographic markets. They will also discuss partnering opportunities, how to maximize visibility in front of large company investors, and the role of M&A. The Main Event is designed for those in the business development and/or financial community who are interested in investment or partnering opportunities with medtech innovators. Medtech innovators give 10-minute presentations on their latest medical device innovations within a wide range of high-growth markets. In between presentation blocks, enjoy dedicated break-out sessions for one-on-one meetings, and networking.

    Benefit From:

  • Nearly 50 presentations by medical technology innovators with the most desired technologies.
  • 20+ finance presentations and perspectives by some of the industry's biggest players.
  • Over two dozen networking opportunities.
  • Partnering Software to identify attendees and plan private, 1-on-1 meetings in advance – all without schedule overlap or program interrupt.
  • Multiple keynote plenary panels on the latest 'deals' case studies, device investing, M&A, health reform, clinicians, and more!
  • Access to current and future news on investing and partnering, as driven by Elsevier Business Intelligence researchers, analysts, and authors.


Over 1,500 emerging medical technology company presenters and more than 8,000 attendees have participated at IN3 events over the past nine years. We are very proud to say that many young companies have worked their way up the funding ladder and into the marketplace via the relationships they formed at IN3 events. Click Here for success stories and testimonials from our past presenters and attendees.

About Partnering
Click Title for More Info
Why Use Windhover Conferences Partnering Software?
  • • Identify attendees to choose potential partners.
  • • Search database of partnering/investing opportunities(including deal history and related articles).
  • • Communicate and pre-schedule as many meetings as you wish with fellow attendees.
  • • Showcase your company's innovative technology and investment/partnering interests.


For more information, please contact:
Kristy Grimes at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.


 

About Partnering

Important Deadlines
Save $100 before: 03/28/2010
Last Chance for Discounted Rooms (may sell out earlier) 04/10/2010
Partnering Opens (start scheduling meetings) 03/31/2010
Innovator Company Profile Due 03/31/2010

Click Here to view full pricing schedule.

Who Attends

  • • Presidents, CEOs, CTOs, COOs
  • • Founders, Chairpersons
  • • Venture Partners
  • • Managing Directors
  • • VPs/Directors of Strategic Planning, Business Development, Marketing, New Technology, Acquisitions, R&D, & Sales
  • • Senior Investment
  • • Analysts/Principals/Directors

From These Types of Companies

  • • Established device companies seeking technology via licensing, partnering, and acquisition to broaden or deepen product lines or build sector strength.
  • • VCs and investment bankers.
  • • Medical device, biopharmaceutical, biotech, or other company executives seeking investments or partnerships.

Benefits of Attending

Potential acquirers/funding partners can meet and screen over 50 hand-selected, first-rate investment possibilities in just two well-orchestrated days, via focused presentations covering widely varied technologies, stages of development and testing, potential markets, management teams, regulatory timeline, patent protection, competitive strategy, funding desired, and much more... Including private break-out sessions and networking events.

Medical device start-ups face intense competition for a finite amount of available capital funding. This makes IN3 events the ideal setting for emerging companies to meet and impress potential investors from many of the top-tier device companies and discerning healthcare investment firms from around the world.

All attendees will gain a keen under-standing (in a short timeframe) of the emerging medical technologies that are on track to make a distinct impact on the intensely-competitive device industry.

Advisory Board

  • Annette Campbell-White
    Senior Managing Member
    MedVenture Associates
  • Michael Carusi
    General Partner
    Advanced Technology Ventures
  • Luke Evnin
    General Partner
    MPM Capital
  • Richard M. Ferrari
    Managing Director
    DeNovo Ventures
  • William T. Harrington
    Partner
    Three Arch Partners
  • Ross A. Jaffe
    Managing Director
    Versant Ventures
  • Josh Makower
    Venture Partner
    NEA
  • John Maroney
    General Partner
    Delphi Ventures
  • Allan May
    Chairman, Founder
    Life Science Angels
    Managing Director
    Emergent Medical Partner
  • David Milne
    Managing Partner
    SV Life Science Advisers
  • Trevor J. Moody
    Partner
    Frazier Healthcare Ventures
  • Jesse I Treu
    Partner
    Domain Associates